These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 37977814)

  • 21. The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication.
    Althaus AL; McCarren HS; Alqazzaz A; Jackson C; McDonough JH; Smith CD; Hoffman E; Hammond RS; Robichaud AJ; Doherty JJ
    Epilepsy Behav; 2017 Mar; 68():22-30. PubMed ID: 28109985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational polytherapy in the treatment of cholinergic seizures.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Suchomelova L; Naylor D; Estrada IBF; Schultz M; Furtado MA; Wasterlain CG
    Neurobiol Dis; 2020 Jan; 133():104537. PubMed ID: 31454548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Risk Factors for Refractory Status Epilepticus.
    Tatro HA; Hamilton LA; Peters C; Rowe AS
    Ann Pharmacother; 2020 Jan; 54(1):14-21. PubMed ID: 31347376
    [No Abstract]   [Full Text] [Related]  

  • 24. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for Efficacious Anticonvulsants and Neuroprotectants in Delayed Treatment Models of Organophosphate-induced Status Epilepticus.
    Barker BS; Spampanato J; McCarren HS; Smolik M; Jackson CE; Hornung EN; Yeung DT; Dudek FE; McDonough JH
    Neuroscience; 2020 Jan; 425():280-300. PubMed ID: 31783100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiseizure Activity of Midazolam in Mice Lacking δ-Subunit Extrasynaptic GABA(A) Receptors.
    Reddy SD; Younus I; Clossen BL; Reddy DS
    J Pharmacol Exp Ther; 2015 Jun; 353(3):517-28. PubMed ID: 25784648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurosteroids and Seizure Activity.
    Miziak B; Chrościńska-Krawczyk M; Czuczwar SJ
    Front Endocrinol (Lausanne); 2020; 11():541802. PubMed ID: 33117274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of midazolam pharmacokinetics in the treatment of status epilepticus.
    Francoeur C; Welsh SS; Ichord R; Abend NS; Topjian AA; Zuppa AF
    Seizure; 2020 Oct; 81():310-314. PubMed ID: 32947180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extrasynaptic γ-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures.
    Reddy DS; Carver CM; Clossen B; Wu X
    Epilepsia; 2019 Apr; 60(4):730-743. PubMed ID: 30895610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment.
    Mitchell WG
    Epilepsia; 1996; 37 Suppl 1():S74-80. PubMed ID: 8647055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus.
    Chuang SH; Reddy DS
    Neuropharmacology; 2019 Apr; 148():244-256. PubMed ID: 30471294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Refractory Status Epilepticus: An International Cohort Study (MORSE CODe) Analysis of Patients Managed in the ICU.
    Chiu WT; Campozano V; Schiefecker A; Rodriguez DR; Ferreira D; Headlee A; Zeidan S; Grinea A; Huang YH; Doyle K; Shen Q; Gómez D; Hocker SE; Rohaut B; Sonneville R; Hong CT; Demeret S; Kurtz P; Maldonado N; Helbok R; Fernandez T; Claassen J
    Neurology; 2022 Sep; 99(11):e1191-e1201. PubMed ID: 35918156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal MRI and TSPO PET-based investigation of brain region-specific neuroprotection by diazepam versus midazolam following organophosphate-induced seizures.
    Hobson BA; Rowland DJ; Dou Y; Saito N; Harmany ZT; Bruun DA; Harvey DJ; Chaudhari AJ; Garbow JR; Lein PJ
    Neuropharmacology; 2024 Jun; 251():109918. PubMed ID: 38527652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Neuropsychiatric Developmental Defects after Neonatal Organophosphate Exposure: Mitigation by Synthetic Neurosteroids.
    Neff MJ; Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):451-468. PubMed ID: 37863488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children.
    Peariso K; Arya R; Glauser T; Abend NS; Barcia Aguilar C; Amengual-Gual M; Anderson A; Appavu BL; Brenton JN; Carpenter J; Chapman KE; Clark J; Gaillard WD; Gaínza-Lein M; Goldstein J; Goodkin H; Grinspan Z; Guerriero RM; Horn PS; Huh L; Kahoud R; Kelley SA; Kossoff EH; Kapur K; Lai YC; Marquis BO; McDonough T; Mikati MA; Morgan L; Novotny E; Ostendorf AP; Payne ET; Piantino J; Riviello J; Sands T; Stafstrom CE; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2023 Aug; 101(5):e546-e557. PubMed ID: 37295955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.
    McTague A; Martland T; Appleton R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD001905. PubMed ID: 29320603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.
    Claassen J; Hirsch LJ; Emerson RG; Mayer SA
    Epilepsia; 2002 Feb; 43(2):146-53. PubMed ID: 11903460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurosteroid replacement therapy for catamenial epilepsy.
    Reddy DS; Rogawski MA
    Neurotherapeutics; 2009 Apr; 6(2):392-401. PubMed ID: 19332335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.
    Holtkamp M
    Drugs; 2018 Mar; 78(3):307-326. PubMed ID: 29368126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy.
    Reddy DS; Mbilinyi RH; Estes E
    Psychopharmacology (Berl); 2023 Sep; 240(9):1841-1863. PubMed ID: 37566239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.